Emmaus Life Sciences Inc
(EMMA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EMMA | AZN | AMGN | GILD | BMY |
| Company | Emmaus Life Sciences Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.0146 | 200.08 | 365.14 | 148.90 | 60.60 |
| High | 0.0155 | 202.54 | 368.51 | 156.52 | 60.98 |
| Low | 0.0146 | 199.19 | 361.00 | 147.38 | 59.66 |
| Latest | 0.0154 | 202.11 | 367.08 | 156.71 | 60.99 |
| Change | +0.0015 | +8.71 | +2.43 | +9.48 | +0.13 |
| % Change | +10.79% | +4.50% | +0.67% | +6.44% | +0.21% |
| Volume | 290,800 | 1,362,484 | 780,897 | 4,800,846 | 2,780,203 |
| 20-Day Average Volume | 51,815 | 4,566,838 | 3,093,290 | 8,308,954 | 13,233,083 |
| Previous Close | 0.0139 | 193.40 | 364.65 | 147.23 | 60.86 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0131 | 187.98 | 349.70 | 139.00 | 56.74 |
| 20-Day Raw Stochastic | 98.18% | 97.38% | 72.97% | 99.77% | 86.65% |
| 20-Day Relative Strength | 61.63 | 63.13 | 61.09 | 73.38 | 68.53 |
| Weighted Alpha | -53.50 | +44.93 | +33.11 | +61.56 | +24.86 |
| Today's Opinion | 24% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 8% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 56% Sell | 100% Buy | 64% Buy | 56% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +10.00% since 01/29/26 | +7.38% since 02/04/26 | +0.49% since 02/04/26 | +6.87% since 02/04/26 | +5.72% since 02/04/26 |
| Low | 0.0136 on 01/30/26 | 186.58 on 02/05/26 | 361.00 on 02/11/26 | 145.87 on 02/05/26 | 58.00 on 02/05/26 |
| High | 0.0155 on 02/09/26 | 201.90 on 02/11/26 | 385.12 on 02/06/26 | 156.36 on 02/11/26 | 62.05 on 02/06/26 |
| 1-Month | |||||
| %Chg | +18.46% since 01/07/26 | +6.33% since 01/09/26 | +12.84% since 01/09/26 | +29.05% since 01/09/26 | +9.05% since 01/09/26 |
| Low | 0.0130 on 01/16/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 53.54 on 01/21/26 |
| High | 0.0155 on 02/09/26 | 201.90 on 02/11/26 | 385.12 on 02/06/26 | 156.36 on 02/11/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | +14.93% since 11/07/25 | +12.96% since 11/11/25 | +8.73% since 11/11/25 | +27.51% since 11/11/25 | +25.03% since 11/11/25 |
| Low | 0.0090 on 11/17/25 | 174.46 on 11/12/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 0.0155 on 02/09/26 | 201.90 on 02/11/26 | 385.12 on 02/06/26 | 156.36 on 02/11/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | +18.46% since 08/08/25 | +35.87% since 08/11/25 | +29.08% since 08/11/25 | +29.73% since 08/11/25 | +32.63% since 08/11/25 |
| Low | 0.0080 on 10/20/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 0.0172 on 10/09/25 | 201.90 on 02/11/26 | 385.12 on 02/06/26 | 156.36 on 02/11/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,081 | 299,945,568 | 196,357,104 | 182,665,312 | 123,895,928 |
| Shares Outstanding, K | 70,188 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 16,650,000 | 54,073,000,000 | 36,751,000,000 | 28,754,000,000 | 48,194,000,000 |
| Annual Net Income | -6,450,000 | 7,035,000,000 | 7,711,000,000 | 480,000,000 | 7,054,000,000 |
| Last Quarter Sales | 3,380,000 | 15,191,000,000 | 9,866,000,000 | 7,769,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -2,080,000 | 2,533,000,000 | 1,333,000,000 | 3,052,000,000 | 1,087,000,000 |
| 60-Month Beta | 9.38 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.03 on 11/14/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 04/13/26 | 02/10/26 | 05/07/26 | 02/10/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.57 | 17.20 | 18.52 | 9.88 |